Dexmedetomidine in neonates: utilisation trends and safety profile over time in a neonatal intensive care unit
Our data and experiences demonstrated a significant increase in the dose and duration of dexmedetomidine use in the NICU over the years. Additionally, the findings have suggested that higher doses and treatment duration do not result in an increase in ADRs during the acute period.
Authors
- Şule Yiğit (ORCID: https://orcid.org/0000-0002-8755-0384)
- Gözdem Kaykı (ORCID: https://orcid.org/0000-0002-8126-3114)
- Nadir Yalçın (ORCID: https://orcid.org/0000-0002-2280-8727)
- Hasan Tolga Çelik (ORCID: https://orcid.org/0000-0002-1725-0722)
Institutions
- Hacettepe University (TR)
- KU Leuven (BE)
Publication Details
- Journal
- BMJ Paediatrics Open
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1136/bmjpo-2024-003004
- Citations
- 7
- Primary Topic
- Anesthesia and Sedative Agents
- Type
- article
- Field-Weighted Citation Impact
- 15.34